RCT Comparing Remimazolam With Propofol Under EEG DSA Guidance During Cardiac Electrophysiology Studies and Ablation
Launched by TAIPEI VETERANS GENERAL HOSPITAL, TAIWAN · Nov 19, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient receives scheduled cardiac electrophysiology studies and ablation by the same cardiologist(one of the study investigator).
- Exclusion Criteria:
- • With existing vasopressor or shock status
- • Patient refusal or cannot finish Mini-Cog or QoR-15 preoperatively
- • Canceled by cardiologist
- • Allergy history to the anesthetics used in this study
- • History of abnormal lung function or required oxygen therapy preoperative
About Taipei Veterans General Hospital, Taiwan
Taipei Veterans General Hospital, located in Taiwan, is a renowned medical institution dedicated to providing comprehensive healthcare and advancing medical research. As a prominent clinical trial sponsor, the hospital is committed to exploring innovative therapies and improving patient outcomes through rigorous scientific studies. With a multidisciplinary team of experienced researchers and clinicians, Taipei Veterans General Hospital prioritizes ethical standards and patient safety while contributing to the global medical community's knowledge base. Its state-of-the-art facilities and collaborative environment foster groundbreaking research that aims to address pressing healthcare challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Trial Officials
Li Yi-Shiuan, Bachelor's
Study Director
Taipei Veterans General Hospital, Taiwan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported